A multicenter, retrospective study of accelerated venetoclax ramp‐up in patients with relapsed/refractory chronic lymphocytic leukemia

Corresponding Author

Matthew S. Davids MD, MMSc

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Correspondence

Matthew S. Davids, MD, MMSc, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA, Tel.: +1.617.632.6331, Email: Matthew_Davids@DFCI.HARVARD.EDU

Search for more papers by this author

Comments (0)

No login
gif